Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL).

Tentori, L

Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL). [electronic resource] - Cancer immunology, immunotherapy : CII Dec 1995 - 375-83 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0340-7004

10.1007/BF01526557 doi


Animals
Antigens, CD--biosynthesis
Antineoplastic Agents, Alkylating--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma--drug therapy
Combined Modality Therapy
Cyclophosphamide--administration & dosage
Cytotoxicity, Immunologic--drug effects
Dacarbazine--administration & dosage
Drug Administration Schedule
Drug Screening Assays, Antitumor
Drug Synergism
Gene Expression Regulation, Neoplastic--drug effects
Immunologic Factors--pharmacology
Integrin alpha6
Interleukin-2--pharmacology
Lung Neoplasms--drug therapy
Male
Mice
Mice, Inbred C57BL
Neoplasm Metastasis--prevention & control
Neoplasm Proteins--biosynthesis
Neoplasm Transplantation
T-Lymphocytes, Cytotoxic--drug effects